FALCO HOLDINGS Co., Ltd. (4671.T)
Tokyo · JPY · Healthcare · Diagnostics & Research
¥2,698 (-1.06%) as of
Key statistics
- Market cap
- 26.64B
- P/E (TTM)
- 13.03
- Forward P/E
- 15.32
- EPS (TTM)
- 206.99
- Dividend yield
- 4.69%
- 52-week range
- 2,470.00 – 2,964.00
- Beta
- 0.32
- Revenue (TTM)
- 43.65B
- Profit margin
- 4.76%
- Volume
- 15.30k
About FALCO HOLDINGS Co., Ltd.
FALCO HOLDINGS Co., Ltd., a medical service company, provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. The company offers clinical testing services in the fields of genetic tests, biochemistry, hematology, pathology, immunology, and microbiology; and genetic testing services for diagnosis of hereditary cancer, reproductive health and companion diagnostics. It also provides medical information technology services; and develops in vitro diagnostics for unmet medical needs. In addition, the company is involved in the dispensing pharmacies and drugstores business; and development and sale of various medical chart systems, including HAYATE / NEO, cloud-based electronic medical record for small and medium-sized hospitals, as well as @home Dr., an electronic medical chart for bed less clinics. FALCO HOLDINGS Co., Ltd. was founded in 1962 and is headquartered in Osaka, Japan.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Osaka, Japan
- Employees
- 1,037
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.